http://orcid.org/0000-0003-1303-5467
About the Authors
- Effy Vayena
-
* E-mail: effy.vayena@hest.ethz.ch
Affiliation Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland
- Alessandro Blasimme
-
Affiliation Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland
- I. Glenn Cohen
-
Affiliation Harvard Law School, Cambridge, Massachusetts, United States of America
Competing Interests
I have read the journal’s policy and the authors of this manuscript have the following competing interests: EV has received speaking fees from SwissRe, Novartis R&D Academy, and Google Netherlands. IGC served as a consultant for Otsuka Pharmaceuticals advising on the use of digital medicine for its Abilify MyCite product. IGC is supported by the Collaborative Research Program for Biomedical Innovation Law, which is a scientifically independent collaborative research program supported by Novo Nordisk Foundation. AB served as a consultant for Celgene Corporation for the preparation of a workshop on pharmaceutical innovation and received honoraria from SwissRe for participating at an internal event on genome editing.